Certified by Founder Lodge
Caristo Diagnostics
United Kingdom - Oxford
START UP
1 Disclosed Funding Rounds $16,300,000
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagnostic tools to patients worldwide. Our proprietary technology transforms the accuracy of routine cardiac CT scan
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 18 ,2023 | Series A | $16,300,000 |
Oxford Science Enterprises
BGF
Oxford Investment Consultants
University of Oxford
Longwall Venture Partners LLP
Moon Surgical
Centerline Biomedical
Cara Care
De Oro Devices
Luminate Medical
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
